1. Articles from gurufocus.com

  2. 25-48 of 60 « 1 2 3 »
    1. EyeGate Pharma Strengthens Scientific Advisory Board with Appointments of Daniel S. Durrie, MD ...

      EyeGate Pharma Strengthens Scientific Advisory Board with Appointments of Daniel S. Durrie, MD ...

      EyeGate Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases and disorders of the eye, today announced the appointment of two leading ophthalmology experts, Daniel S. Durrie, M.D. and Randall J. Olson, M.D., to its Scientific Advisory Board...

      Read Full Article
    2. Pershing Square Gains Board Seat on Valeant

      Pershing Square Gains Board Seat on Valeant

      Bill Ackman says Valeant could sell off Bausch & Lomb segment to pay debt Check out Bill Ackman Stock Picks » Download GuruFolio Report of Bill Ackman (Updated on 03/10/2016) , Check out Ruane Cunniff Stock Picks » Download GuruFolio Report of Ruane Cunniff (Updated on 03/10/2016) , Check out Jeff Ubben Stock Picks » Download GuruFolio Report of Jeff Ubben (Updated on 03/10/2016) , Check out ...

      Read Full Article
    3. Why ValueAct Capital Is Buying Towers Watson

      Why ValueAct Capital Is Buying Towers Watson

      Exploring the logic behind ValueAct's most recent buy of the high-quality business services firm Check out Jeff Ubben Stock Picks » Download GuruFolio Report of Jeff Ubben (Updated on 11/18/2015) , Check out Carl Icahn Stock Picks » Download GuruFolio Report of Carl Icahn (Updated on 11/18/2015) , Check out Joel Greenblatt Stock Picks » Download GuruFolio Report of Joel Greenblatt (Updated on 11 ...

      Read Full Article
    4. The Stellar Kraft Heinz Board of Directors

      The Stellar Kraft Heinz Board of Directors

      On July 6, 2015, shares of Kraft Heinz (KHC) began trading. This company, representing the merger of Kraft Foods Group and H.J. Heinz, is currently valued at about $100 billion at its closing price of $77.31 on July 10. Berkshire Hathaway (BRK.A, BRK.B) owns about 325 million shares, which represents approximately one quarter of the company, and is valued at $25 billion...

      Read Full Article
    5. A Short Discussion on Executive Compensation

      A Short Discussion on Executive Compensation

      “I think I’ve been in the top 5 percent of my age cohort almost all my adult life in understanding the power of incentives, and all my life I have always underestimated that power.” -Charlie Munger (Trades, Portfolio) “Knowing is not enough; we must apply. Being willing is not enough; we must do.” - Leonardo Da Vinci In his talk at Harvard about human misjudgment, Charlie Munger (Trades, Portfolio) has admitted that all his life he has under-estimated the power of incentives...

      Read Full Article
    6. Acquisition in the Health Care Industry Increased Volatility

      Acquisition in the Health Care Industry Increased Volatility

      In a previous article we discussed some reasons why Bill Ackman (Trades, Portfolio) initiated a position in Valeant Pharmaceuticals International (VRX) to $3.87 billion, according to the fund's latest filing. On Friday, shares were down about 2% to $228.83. According to the Wall Street Journal, there was a potential buyout offer to buy animal-health giant Zoetis (ZTS)...

      Read Full Article
    25-48 of 60 « 1 2 3 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content